Thank you to everybody for the work that you are doing, these are incredibly tough times and the last 20 months have been unparalleled in our careers as health care professionals. What is coming in the next few months may be even more challenging, therefore the UKKA and renal community COVID-19...

There continues to be uncertainty around the new Omicron COVID-19 variant, but the spread of the variant is increasing rapidly throughout the UK and will soon become the dominant variant.There is increasing evidence that people with kidney disease who have had two vaccines are at substantially...

Here at the UK Renal Registry (UKRR), we recognise that a lot of people have contributed to the work that we do, freely giving their own time and with very little direct recognition.In 2013, a new award was created, the ‘Terry Feest’ award, in recognition of the contribution made by Terry, not only...

Appointed in 1981, Dr Dwomoa (Jo) Adu, Consultant Nephrologist, gives an overview of his career highlights

Applications are now invited for the Francis Crick Institute PhD for Clinicians.The fellowships provide an opportunity for talented clinicians passionate about research, with a strong academic track record, to perform biomedical discovery research while following our three-year clinical PhD...

Ensuring more kidney patients have the opportunity for dialysis at home, and creating greater and equitable access to kidney transplantation, are among the key measures outlined in a new national report for renal medicine from the Getting It Right First Time (GIRFT) programme.The report, written by...

The UK Kidney Association Clinical Practice Guideline Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease has now been published. "SGLT-2 inhibitors represent the most significant advance in the management of progressive CKD identified over the last 20 years and the...

The UKKA Training and Education Committee is seeking someone with experience in the clinical management of renal services, locally or regionally, to help them design a bespoke management course. The successful candidate will work alongside the Committee to help ensure this course delivers the...

Clarification on kidney patients who are eligible for the third primary or booster COVID-19 vaccination is now available.Further to their recommendations on third primary vaccination JCVI have now recommended a booster vaccine dose for patient groups that include patients on dialysis and CKD 3-5...

The UK Kidney Association (UKKA) welcomes the announcement by the JCVI recommending a third dose of an mRNA COVID-19 vaccine in kidney patients who are receiving immunosuppression treatment. This decision is a response to extensive scientific data showing that many of these kidney patients have a...